Remer Thomas, Manz Friedrich, Hartmann Michaela F, Schoenau Eckhard, Wudy Stefan A
Department of Nutrition and Health, Research Institute of Child Nutrition, Forschungsinstitut für Kinderernährung, Heinstück 11, 44225 Dortmund, Germany.
J Clin Endocrinol Metab. 2009 Feb;94(2):575-8. doi: 10.1210/jc.2008-1375. Epub 2008 Nov 11.
During the physiological process of adrenarche, the adrenal glands of healthy children secrete increasing amounts of weak androgenic steroids partly metabolized to potent sex steroids.
The aim of the study was to examine whether adrenal androgen metabolite excretion rates before the onset of puberty may be prospectively associated with late-pubertal diaphyseal bone strength.
We conducted the study in an auxological and metabolic child nutrition research facility.
The sample included 45 healthy adolescents who underwent proximal forearm bone and muscle area measurements by peripheral quantitative computed tomography at the age of 16 yr (SD 1.5) and who had collected a 24-h urine sample 8 yr earlier, allowing to quantify the prepubertal urine metabolome. Prepubertal hormonal predictors quantified by gas chromatography-mass spectrometry were: dehydroepiandrosterone, its 16-hydroxylated downstream metabolites, 5-androstene-3beta,17beta-diol (androstenediol), sums of total androgen and glucocorticoid metabolites, cortisol, and 6beta-hydroxycortisol.
Proximal forearm radius was measured.
Of all prepubertal hormones analyzed, only sex- and age-specific androstenediol levels significantly predicted pubertal stage-, height-, and muscularity-adjusted diaphyseal bone modeling (periosteal circumference, beta = 0.67, P = 0.002; cortical area, beta = 2.15, P = 0.02), bone mineral content (beta = 2.2; P = 0.04), and polar strength strain index (beta = 12.2; P = 0.002). Androstenediol explained 5-10% of the late-pubertal diaphyseal radius variability.
Our prospective profiling of urinary steroid metabolites in 24-h urine samples collected before puberty suggests that androstenediol is an early predictor of the diaphyseal bone strength in late puberty. This predominantly peripheral conversion product of adrenarchal dehydroepiandrosterone by 17beta-hydroxysteroid dehydrogenase may hence be involved in a sustained improvement of radial bone accretion during growth.
在肾上腺初现的生理过程中,健康儿童的肾上腺会分泌越来越多的弱雄激素类固醇,其中部分会代谢为强效性类固醇。
本研究旨在探讨青春期开始前肾上腺雄激素代谢产物的排泄率是否可能与青春期后期骨干骨强度存在前瞻性关联。
我们在一个儿童生长发育与代谢营养研究机构开展了这项研究。
样本包括45名健康青少年,他们在16岁(标准差1.5)时通过外周定量计算机断层扫描测量了前臂近端的骨和肌肉面积,并且在8年前采集了24小时尿液样本,以便对青春期前的尿液代谢组进行定量分析。通过气相色谱 - 质谱法定量的青春期前激素预测指标包括:脱氢表雄酮、其16 - 羟基化下游代谢产物、5 - 雄烯 - 3β,17β - 二醇(雄烯二醇)、总雄激素和糖皮质激素代谢产物总和、皮质醇以及6β - 羟基皮质醇。
测量前臂近端桡骨。
在所有分析的青春期前激素中,只有性别和年龄特异性的雄烯二醇水平能显著预测青春期阶段、身高和肌肉量调整后的骨干骨建模(骨膜周长,β = 0.67,P = 0.002;皮质面积,β = 2.15,P = 0.02)、骨矿物质含量(β = 2.2;P = 0.04)以及极向强度应变指数(β = 12.2;P = 0.002)。雄烯二醇解释了青春期后期骨干桡骨变异性的5% - 10%。
我们对青春期前采集的24小时尿液样本中尿类固醇代谢产物进行的前瞻性分析表明,雄烯二醇是青春期后期骨干骨强度的早期预测指标。这种主要由肾上腺初现的脱氢表雄酮经17β - 羟基类固醇脱氢酶在外周转化产生的产物,可能因此参与了生长过程中桡骨骨量的持续增加。